SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE195.306.6 (+3.5 %)
PREV CLOSE ( ) 188.70
OPEN PRICE ( ) 188.70
BID PRICE (QTY) 195.20 (129)
OFFER PRICE (QTY) 195.55 (119)
VOLUME 90539
TODAY'S LOW / HIGH ( )188.70 198.20
52 WK LOW / HIGH ( )108.2 289
NSE195.186.13 (+3.24 %)
PREV CLOSE( ) 189.05
OPEN PRICE ( ) 189.05
BID PRICE (QTY) 195.10 (16)
OFFER PRICE (QTY) 195.19 (40)
VOLUME 825055
TODAY'S LOW / HIGH( ) 189.05 198.20
52 WK LOW / HIGH ( )108 289
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.